On September 1, 2022, Mr. Gerard van Hamel Platerink informed the Board of Directors of Augmedix, Inc. of his decision to resign as director and Chairman of the Board, including as a member of its Compensation Committee and Chair of its Nominating and Corporate Governance Committee, effectively as of September 2, 2022. Mr. van Hamel Platerink's resignation follows his departure from Redmile Group LLC earlier this year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8524 USD | +3.95% | -7.16% | -85.43% |
06-04 | Augmedix, Inc. Reiterates Earnings Guidance for the Second Quarter and Full Year of 2024 | CI |
05-29 | Augmedix Appoints Alex Stinard as Chief Clinical AI Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.43% | 41.74M | |
+13.19% | 69.22B | |
+7.13% | 17.41B | |
+23.31% | 13.83B | |
+8.67% | 13.35B | |
+13.99% | 9.93B | |
-20.79% | 6.73B | |
-3.95% | 6B | |
+1.45% | 5.17B | |
+6.18% | 4.74B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Augmedix, Inc. Announces Resignation of Gerard Van Hamel Platerink as Director